DGKZ and neoplasm: This may be because DGKζ-deficient T cells are significantly resistant to several immunosuppressive factors within the tumor microenvironment such as TGFβ, PGE2 and adenosine, and to other T cell inhibitory pathways such as PD1 [236,238,239,242].